Urinary Continence Index for Prediction of Urinary Incontinence in Older Women

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Ananias Diokno, William Beaumont Hospitals
ClinicalTrials.gov Identifier:
NCT01479816
First received: November 22, 2011
Last updated: September 4, 2014
Last verified: September 2014
  Purpose

This study will analyse existing data to establish a clinically useful index to predict those women who are more likely to become incontinent. This would create significant opportunities for focused prevention and early intervention strategies.


Condition
Urinary Incontinence

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Retrospective
Official Title: Urinary Continence Index for Prediction of Urinary Incontinence in Older Women

Resource links provided by NLM:


Further study details as provided by William Beaumont Hospitals:

Primary Outcome Measures:
  • Index Estimation for Urinary Incontinence Prediction [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    Several risk factors identified can serve as an index in predicting the development of urinary incontinence in elderly women.


Secondary Outcome Measures:
  • Predictive Reliability of Urinary Incontinence Index and its Validation [ Time Frame: 3 years ] [ Designated as safety issue: No ]
    The urinary continence index developed in Outcome measure 1 will reliably predict the development of urinary incontinence in women when tested against existing datasets.


Estimated Enrollment: 1
Study Start Date: September 2011
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   55 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Women 55 years and older

Criteria

Inclusion Criteria:

  • Women

Exclusion Criteria:

  • Men
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01479816

Locations
United States, Michigan
Oakland University
Rochester, Michigan, United States, 48309
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073
Sponsors and Collaborators
Ananias Diokno
Investigators
Principal Investigator: Ananias Diokno, MD William Beaumont Hospitals
  More Information

No publications provided

Responsible Party: Ananias Diokno, Principal Investigator, William Beaumont Hospitals
ClinicalTrials.gov Identifier: NCT01479816     History of Changes
Other Study ID Numbers: E2011-047, 1R01AG038673
Study First Received: November 22, 2011
Last Updated: September 4, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by William Beaumont Hospitals:
continence
index

Additional relevant MeSH terms:
Urinary Incontinence
Urination Disorders
Urologic Diseases
Lower Urinary Tract Symptoms
Urological Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on October 19, 2014